Q7A5Y5 AF NFT

DNA topoisomerase 1

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifm7v4jiqrltmuo5ksentdnevjtpvoukylfychtllbar54sumtu5a/metadata.json
IPFS of structure file: 
bafybeic5p5hkssdoux322iunpeeqafi5hlnuilowur5th4bchejjruwooa/AF-Q7A5Y5-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xBABc9DC7023be831DDdB1D7F196c6336E7D131B7
First NFT owner address (bech32): 
genesis1h27fm3cz805rrhwmr4l3jmrrxmnazvdhz9rdlt
Current NFT ID #469984 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
469984
Accession (UniProt):
Q7A5Y5
Name::
DNA topoisomerase 1
Experimental Method:
Predicted structure
Sequence source:
STAPHYLOCOCCUS AUREUS (STRAIN N315)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q7A5Y5 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q7A5Y5|TOP1_STAAN DNA topoisomerase 1 OS=Staphylococcus aureus (strain N315) OX=158879 GN=topA PE=1 SV=1 MADNLVIVESPAKAKTIEKYLGKKYKVIASMGHVRDLPRSQMGVDTEDNYEPKYITIRGKGPVVKELKKHAKKAKNVFLASDPDREGEAIAWHLSKILELEDSKENRVVFNEITKDAVKESFKNPREIEMNLVDAQQARRILDRLVGYNISPVLWKKVKKGLSAGRVQSVALRLVIDRENEIRNFKPEEYWTIEGEFRYKKSKFNAKFLHYKNKPFKLKTKKDVEKITAALDGDQFEITNVTKKEKTRNPANPFTTSTLQQEAARKLNFKARKTMMVAQQLYEGIDLKKQGTIGLITYMRTDSTRISDTAKAEAKQYITDKYGESYTSKRKASGKQGDQDAHEAIRPSSTMRTPDDMKSFLTKDQYRLYKLIWERFVASQMAPAILDTVSLDITQGDIKFRANGQTIKFKGFMTLYVETKDDSDSEKENKLPKLEQGDKVTATQIEPAQHYTQPPPRYTEARLVKTLEELKIGRPSTYAPTIDTIQKRNYVKLESKRFVPTELGEIVHEQVKEYFPEIIDVEFTVNMETLLDKIAEGDITWRKVIDGFFSSFKQDVERAEEEMEKIEIKDEPAGEDCEVCGSPMVIKMGRYGKFMACSNFPDCRNTKAIVKSIGVKCPKCNDGDVVERKSKKNRVFYGCSKYPECDFISWDKPIGRDCPKCNQYLVENKKGKTTQVICSNCDYKEAAQK